Sign in
4

Changes in Ownership

PRECISION BIOSCIENCES INC Filed Acc 0001209191-21-026663

President and CEO sold 9,741 shares at $8.67 ($84,454)

  • President and CEO acquired 21,514 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KANE MATTHEW R. President and CEO 2021-04-12 Option exercise +21,514 $0.04 $861 1,974,537 D
KANE MATTHEW R. President and CEO 2021-04-12 Sale −9,741 $8.67 $84,454 1,964,796 D
Derivatives
KANE MATTHEW R. President and CEO 2021-04-12 Option exercise · Employee Stock Option (Right to Buy) −21,514 64,542 D
Open-market sales · 9,741 sh · avg $8.67 · $84,454
Loading xslF345X03/doc4.xml…